Biotechnology News

July 15, 2014

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced today the completion...

July 15, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today introduced a molecular solution that combines its Oligo Library Synthesis capability for FISH (fluorescence in situ hybridization) with its SureDesign online...

July 15, 2014

CHICAGO--(BUSINESS WIRE)--“The stage is set for a greater percentage of the $6.5 trillion in IRA assets to move into private equity deals,” says Scott Jordan, Founder, HealthiosXchange (“H/X”).

July 15, 2014

MINNEAPOLIS--(BUSINESS WIRE)--The Medica Research Institute announces the creation of the Distinguished Chair in Health Policy. The position will be held by a nationally recognized research expert in health policy.

July 15, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its second quarter 2014 financial results at 4:00 p.m. ET on Tuesday, July 22, 2014. In connection with this announcement, Cubist will host a conference...

July 15, 2014

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central...

July 15, 2014

BEVERLY, Mass.--(BUSINESS WIRE)--RAN Biotechnologies, http://www.ranbiotechnologies.com, has entered into an agreement with Fluigent in Paris for...

July 15, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) (“the Company” or “RegeneRx”) today announced that a new paper entitled, Thymosin β4 Prevents Cardiac Rupture and Improves Cardiac Function in Mice with Myocardial...

July 15, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) will host a webcast and conference call, including an open question and answer session, Tuesday, July 29, 2014. During the call, management will discuss the Company’s financial results...

July 15, 2014

LOS ANGELES--(BUSINESS WIRE)--BG Medical Technologies, Inc. (OTC: RIGH) will be creating a new subsidiary, Genius Biotech Corporation, to specialize in the healthcare aspects of medical marijuana.

July 15, 2014

ITINGEN, Switzerland--(BUSINESS WIRE)--Harlan Laboratories, Ltd. and Fluofarma have announced a strategic partnership that will strengthen the companies’ drug discovery and translational medicine services.

July 15, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research and Excel Life Sciences (ELS) have formed a strategic relationship to bolster Theorem’s clinical development offerings in India, including local site management expertise.

July 15, 2014

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI receives $225,000 NIH research grant to develop Rheumatoid Arthritis treatment.

July 15, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Transcriptic, a cloud-based research services provider, today announced the launch of Transcriptic Platform, a programmable system for defining and executing experimental protocols that have proven to create a 10-...

July 15, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Announces Positive Pre-Clinical Data for Oral Galectin-3 Inhibitor in Nonalcoholic Steatohepatitis (NASH)

July 15, 2014

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that its affiliate, Iroko Pharmaceuticals Inc., has signed a licensing agreement...

July 15, 2014

GRAND PRAIRIE, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with a portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (...

July 15, 2014

CHICAGO--(BUSINESS WIRE)--RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company, announced today that it closed its private placement, which raised approximately $35.6 million in gross proceeds. RestorGenex received net...

July 15, 2014

AMERSHAM, England--(BUSINESS WIRE)--Phlexglobal, the specialist provider of innovative expertise, solutions & services to the life sciences industry, announced today that it has been acquired by Bridgepoint Development Capital.

July 15, 2014

WASHINGTON & BRISTOL, England--(BUSINESS WIRE)--AAAS partners with Jisc to make the entire Science Classic archives available to scholars and students at higher and further education institutions in the United Kingdom.

July 15, 2014

DORTMUND, Germany--(BUSINESS WIRE)--CellAct Pharma has received orphan designation in the EU for CAP7.1 in the treatment of biliary tract cancers.

July 15, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License...

July 15, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Biolase announces inducement grant for under NASDAQ Listing Rule 5635(C)(4)

July 14, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina Inc. (NASDAQ:ILMN) today announced that Tina S. Nova, Ph.D. has been named Senior Vice President and General Manager of Illumina’s oncology business. Nova will lead the company’s strategy for enabling the...

July 14, 2014

BOSTON--(BUSINESS WIRE)--Vertex will announce its second quarter 2014 financial results on Tuesday, July 29 after the market closes. A conference call will follow beginning at 5:00pm ET.

July 14, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for second quarter ended June 30, 2014, on Thursday, August 7, 2014. Lode Debrabandere, Ph.D., President and Chief...

July 14, 2014

SEATTLE--(BUSINESS WIRE)--The Washington Biotechnology & Biomedical Association, the state’s life sciences trade association, announced that its board of directors has appointed ten new members.

July 14, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced top-line results from a Phase 2b monotherapy clinical trial of TC-1734 as a...

July 14, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Zycus has demonstrated a strong capability and deep expertise for rapidly and accurately classifying, enriching and transforming ERP and other spend transaction data into procurement-centric views.

July 14, 2014

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics has acquired rights to new technologies developed at Washington University School of Medicine to commercialize a clinical blood test for detection of early Alzheimer's Disease.

July 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ: XLRN) appoints Terrence C. Kearney to its Board of Directors and to the position of Chair of the Audit Committee.

July 14, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth Hires Medical Director for U.S. Next-Gen Sequencing Lab

July 14, 2014

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation has announced a product development agreement with Mellitus LLC of Cambridge, Mass., involving the development of a new in vitro diagnostic test for gestational diabetes.

July 14, 2014

NEW YORK--(BUSINESS WIRE)--BIOTECHNOLOGY ANALYST BORIS PEAKER JOINS COWEN’S EQUITY RESEARCH DEPARTMENT

July 14, 2014

SAN DIEGO--(BUSINESS WIRE)--DermTech Publishes Clinical Data in the Journal of American Academy of Dermatology

July 14, 2014

ST. PAUL, Minn. & WILMINGTON, Mass.--(BUSINESS WIRE)--St. Jude Medical announces a definitive agreement to acquire NeuroTherm. The acquisition is expected to accelerate growth of St. Jude Medical’s chronic pain business.

July 14, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) announced today the issuance of 14 new patents to BioTime and its subsidiary companies. The patents issued in Australia, Canada, China, Japan, and the United States, cover a wide...

July 14, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Trevi Therapeutics initiates pivotal study of Nalbuphine ER in uremic pruritus.

July 14, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA’s biopharmaceutical division today announced the appointment of Luciano Rossetti, M.D., as Executive Vice President and Global Head of Research & Development as of July 21, 2014.

July 14, 2014

NEW YORK--(BUSINESS WIRE)--BTIG LLC, a global financial services firm specializing in institutional trading and related brokerage services, announced that Hartaj Singh has joined the firm as a Director and Biotechnology Analyst

July 14, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on July 11, 2014, the Company’s issued share capital, excluding...

July 14, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that it has filed an investor presentation with the Securities and Exchange Commission (“SEC”) and posted the presentation under the “...

July 14, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, July 31, 2014. The schedule for the press release...

July 14, 2014

SAN DIEGO--(BUSINESS WIRE)--Results of a health economics study in the Journal of Medical Economics found that use of bioTheranostics’ CancerTYPE ID® molecular test is a cost-effective approach to patient care.